Sfoglia per AUTORE
MOIA R
Collezione AOU Novara

  

Items : 31

Liquid Biopsy in B and T Cell Lymphomas: From Bench to Bedside. in International journal of molecular sciences / Int J Mol Sci. 2025 May 19;26(10):4869. doi: 10.3390/ijms26104869.
2025
AOU Novara

Almasri M; Maher N; Al Deeban B; Diop NM; Moia R; Gaidano G;

A Comprehensive Genetic Study of Classical Hodgkin Lymphoma Using Circulating Tumor DNA. in Blood / Blood. 2025 May 13:blood.2024027355. doi: 10.1182/blood.2024027355.
2025
AOU Novara

Pirosa MC; Bruscaggin A; Terzi di Bergamo L; Salehi M; Jauk F; Forestieri G; Bocchetta S; Piffaretti D; Moia R; Cristaldi V; di Trani M; Galimberti GA; Pini K; Spina V; Giordano C; Condoluci A; Romano I; Annunziata S; Bergesio F; Boldorini R; Borsatti E; Bulian P; Calabretta E; Chauvie S; Corrado F; Crisci S; Cuzzocrea M; De Filippi R; Gerber B; et alii...

Venetoclax therapy in chronic lymphocytic leukaemia patients relapsed after allogeneic haematopoietic stem cell transplantation. in British journal of haematology / Br J Haematol. 2025 Mar;206(3):924-929. doi: 10.1111/bjh.19976. Epub 2025 Jan 7.
2025
AOU Alessandria
AO Cuneo
AOU Città della Salute di Torino
AOU Novara

Vitale C; Coscia M; Bruno B; Rambaldi A; Laurenti L; Krampera M; Gaidano G; Rivela P; Quaglia FM; Quaresmini G; Moia R; Innocenti I; Deodato M; Frustaci AM; Catania G; Montalbano MC; Perutelli F; Boccellato E;

Impairment of the T cell memory response in chronic lymphocytic leukemia patients after SARS-CoV-2 vaccination. in Vaccine / Vaccine. 2025 Feb 27;48:126723. doi: 10.1016/j.vaccine.2025.126723. Epub 2025 Jan 18.
2025
AOU Novara

Raineri D; Mazzucca CB; Moia R; Bruna R; Kustrimovic N; Cappellano G; Bellan M; Perazzi M; Gaidano G; Chiocchetti A;

Venetoclax based regimens in octogenarian CLL patients: efficacy, safety and comparison to BTKi in a multicenter cohort. in Blood advances / Blood Adv. 2025 Apr 16:bloodadvances.2025015818. doi: 10.1182/bloodadvances.2025015818.
2025
AOU Novara

Serafin A; Cellini A; Martino EA; Mazzetto F; Angotzi F; Frustaci AM; Marchetti M; Moia R; Sanna A; Riemma C; Cibien F; Noto A; Lista E; Foglietta M; Vitale C; Innao V; Bullo M; Lovato E; Ferrarini I; Andriola C; Ballotta L; Innocenti I; Fresa A; Favrin G; Varettoni M; Santambrogio E; Orsucci L; Pasquale R; Moratti M; et alii...

2024
AOU Città della Salute di Torino
AOU Novara

Popov VM; Pangalis GA; Espinet B; Bosch F; Sportoletti P; Panagiotidis P; Gozzetti A; Oscier D; Zuchnicka J; Yassin M; Yañez L; Yagci M; Xu Z; Walewska R; Vukovic V; Vrachiolias G; Vitale C; Visentin A; Vassilakopoulos T; Tse E; Tomic K; Tadmor T; Stilgenbauer S; Soliman DSA; Smirnova S; Simkovic M; Shokralla T; Shen Y; Schiwitza A; et alii...

A Rare Case of Life-Threatening Jaundice Caused by Epstein-Barr Virus Infection and Secondary Cold Agglutinin Syndrome Successfully Treated with Rituximab. in International medical case reports journal / Int Med Case Rep J. 2024 Oct 22;17:861-867. doi: 10.2147/IMCRJ.S477296. eCollection 2024.
2024
AOU Novara

Bellia M; Greco M; Lunghi M; Moia R; Gaidano G; Patriarca A;

Other malignancies in the history of CLL: an international multicenter study conducted by ERIC, the European Research Initiative on CLL, in HARMONY. in EClinicalMedicine / EClinicalMedicine. 2023 Nov 15;65:102307. doi: 10.1016/j.eclinm.2023.102307. eCollection 2023 Nov.
2023
AOU Città della Salute di Torino
AOU Novara

Claus R; Biderman B; Antic D; Angelopoulou M; Zuchnicka J; Yassin M; Yañez L; Yagci M; Xu Z; Wasik-Szczepanek E; Walewska R; Vukovic V; Vrachiolias G; von Tresckow J; Vitale C; Visentin A; Vassilakopoulos T; Tomic K; Tse E; Spacek M; Tadmor T; Abdelrahman Soliman DS; Smirnova S; Simkovic M; Shen Y; Schiwitza A; Schipani M; Daniel de Deus Santos M; Ruchlemer R; et alii...

The time to first treatment is an independent predictor of overall survival in chronic lymphocytic leukemia. in American journal of hematology / Am J Hematol. 2023 Jul;98(7):E157-E160. doi: 10.1002/ajh.26927. Epub 2023 Apr 17.
2023
AOU Novara

Morabito F; Tripepi G; Mauro FR; Laurenti L; Reda G; Moia R; Condoluci A; Vincelli I; Chiarenza A; Vigna E; Martino EA; Bruzzese A; Mezzatesta S; Laureana R; Cutrona G; Di Raimondo F; Fronza G; Zucchetto A; Bomben R; Rossi FM; Olivieri J; Zaja F; Rossi D; Gaidano G; Del Principe MI; Ilariucci F; Del Poeta G; Ferrarini M; Neri A; et alii...

Role of chemotherapy in the treatment of chronic lymphocytic leukemia in the era of targeted therapies in Italy. A Campus CLL network report. in Hematological oncology / Hematol Oncol. 2023 Feb;41(1):201-204. doi: 10.1002/hon.3047. Epub 2022 Aug 19.
2023
AOU Città della Salute di Torino
AOU Novara

Foà R; Moia R; Cuneo A; Reda G; Gottardi D; Chiurazzi F; Orsucci L; Maccaferri M; De Paoli L; Marasca R; Ballotta L;

Lymphadenopathy as a predictor of progression during venetoclax treatment in chronic lymphocytic leukemia. A campus chronic lymphocytic leukemia study. in Hematological oncology / Hematol Oncol. 2023 Dec;41(5):877-883. doi: 10.1002/hon.3199. Epub 2023 Jul 1.
2023
AOU Città della Salute di Torino
AOU Novara

Cuneo A; Foà R; Trentin L; Gattei V; Coscia M; Mattiello V; Rigolin GM; Gentile M; Moia R; Scortechini I; Sportoletti P; Catania G; Loseto G; Chiurazzi F; Malerba L; De Paolis MR; Angeletti I; Ferrari A; Giordano A; Baratè C; Quaresmini G; Farina L; Fresa A; Leone MMA; Piciocchi A; Vitale C; Visentin A; Reda G; Innocenti I; et alii...

Long-term follow-up of rituximab plus bendamustine and cytarabine in older patients with newly diagnosed MCL. in Blood advances / Blood Adv. 2023 Aug 8;7(15):3916-3924. doi: 10.1182/bloodadvances.2023009744.
2023
AOU Alessandria
AOU Città della Salute di Torino
AOU Novara

Merli F; Arcari A; Zilioli VR; Re A; Volpetti S; Stelitano C; Quaglia FM; Pileri SA; Bruna R; Ferrante M; Sciarra R; Zambello R; Zanni M; Di Rocco A; Ghiggi C; Chini C; Cencini E; Celli M; Puccini B; Tani M; Botto B; Spina M; Ferrero S; Evangelista A; Patti C; Moia R; Tisi MC; Visco C;

Long-term benefit of IGHV mutated patients in a real-life multicenter cohort of FCR-treated chronic lymphocytic leukemia. in Hematological oncology / Hematol Oncol. 2023 Aug;41(3):567-570. doi: 10.1002/hon.3080. Epub 2022 Oct 10.
2023
AOU Novara

Moia R; Dondolin R; De Propris MS; Talotta D; Mouhssine S; Perutelli F; Reda G; Mattiello V; Rigolin GM; Motta M; Olivieri J; Fanin R; Perbellini O; Ferrarini I; Mauro FR; Del Giudice I; Laurenti L; Tomasso A; Gentile M; Frustaci AM; Tedeschi A; Gozzetti A; Stelitano C; Visco C; Moreno C; Forconi F; Marasca R; Coscia M; Rossi D; et alii...

2022
AOU Città della Salute di Torino
AOU Novara

Trentin L; Foa' R; Cuneo A; Tedeschi A; Gaidano G; Coscia M; Guarente V; Noto A; Ielo C; Deodato M; Stelitano C; Del Poeta G; Giordano A; Levato L; Rigolin GM; Gentile M; Moia R; Murru R; De Paoli L; Laurenti L; Chiarenza A; Ciolli S; Vitale C; Frustaci AM; Mauro FR; Sportoletti P; Reda G; Visentin A; Giannarelli D; et alii...

2022
AOU Città della Salute di Torino
AOU Novara

Pompili M; Trentin L; Tedeschi A; Mauro FR; Scarfò L; Del Poeta G; Autore F; Tomasso A; Arena V; Di Sevo D; Rughini A; Piciocchi A; Frustaci AM; Ielo C; Deodato M; Cassin R; Albano F; Quaglia FM; Pennese E; Gentile M; Murru R; Moia R; Motta M; Coscia M; Visentin A; Innocenti I; Reda G; Foà R; Ghia P; et alii...

2022
AOU Alessandria
AOU Città della Salute di Torino
AOU Novara

Ghia P; Colia M; Ranghetti P; Perotta E; Capasso A; Varettoni M; Laurenti L; Coscia M; Rivela P; Sancetta R; Motta M; Reda G; Ferrario A; Moia R; Deodato M; Farina L; Schiattone L; Albi E; Scarano E; Heltai S; Scarfò L;

Multiregional sequencing and circulating tumour DNA analysis provide complementary approaches for comprehensive disease profiling of small lymphocytic lymphoma. in British journal of haematology / Br J Haematol. 2021 Oct;195(1):108-112. doi: 10.1111/bjh.17718. Epub 2021 Jul 22.
2021
AOU Novara

Moia R; Favini C; Ferri V; Forestieri G; Terzi Di Bergamo L; Schipani M; Sagiraju S; Andorno A; Rasi S; Adhinaveni R; Talotta D; Al Essa W; De Paoli L; Margiotta Casaluci G; Patriarca A; Boldorini RL; Rossi D; Gaidano G;

Assessment of the 4-factor score: Retrospective analysis of 586 CLL patients receiving ibrutinib. A campus CLL study. in American journal of hematology / Am J Hematol. 2021 May 1;96(5):E168-E171. doi: 10.1002/ajh.26127. Epub 2021 Feb 24.
2021
AOU Città della Salute di Torino
AOU Novara

Gattei V; Foà R; Ferrarini M; Trentin L; Polliack A; Gaidano G; Cuneo A; Di Raimondo F; Rossi D; Fronza G; Cutrona G; Neri A; Bomben R; Del Giudice I; Biagi A; Angeletti I; Rago A; D'Arrigo G; Galimberti S; Cassin R; Botta C; Caracciolo D; Mendicino F; Vigna E; Martino EA; Zucchetto A; Rossi FM; Scortechini I; Loseto G; et alii...

The Biology of Chronic Lymphocytic Leukemia: Diagnostic and Prognostic Implications. in Cancer journal (Sudbury, Mass.) / Cancer J. 2021 Jul-Aug 01;27(4):266-274. doi: 10.1097/PPO.0000000000000534.
2021
AOU Novara

Moia R; Patriarca A; Schipani M; Gaidano G;

Survival risk score for real-life relapsed/refractory chronic lymphocytic leukemia patients receiving ibrutinib. A campus CLL study. in Leukemia / Leukemia. 2021 Jan;35(1):235-238. doi: 10.1038/s41375-020-0833-x. Epub 2020 Apr 14.
2021
AOU Città della Salute di Torino
AOU Novara

Gattei V; Cuneo A; Foà R; Polliack A; Gaidano G; Di Raimondo F; Bomben R; Rossi D; Rigolin GM; Del Giudice I; Biagi A; Arrigo G; Rago A; Angeletti I; Botta C; Tripepi G; Vigna E; Fraticelli V; Rossi FM; Zucchetto A; Scortechini I; Consoli U; Pietrasanta D; Loseto G; Moia R; Chiarenza A; Condoluci A; Murru R; Varettoni M; et alii...

Electronic case report forms generation from pathology reports by ARGO, automatic record generator for onco-hematology. in Scientific reports / Sci Rep. 2021 Dec 10;11(1):23823. doi: 10.1038/s41598-021-03204-z.
2021
AOU Città della Salute di Torino
AOU Novara

Di Rocco A; Quaglia FM; Moia R; Ferrero S; Fama A; Grieco LA; Angiulli V; Quinto AM; Rossini B; Minoia C; Loseto G; Opinto G; Scattone A; Esposito F; Vegliante MC; Pavone F; Clemente F; Colucci S; Colella V; Zaccaria GM; Tabanelli V; Guarini A; Ciavarella S;

TP53 disruption as a risk factor in the era of targeted therapies: A multicenter retrospective study of 525 chronic lymphocytic leukemia cases. in American journal of hematology / Am J Hematol. 2021 Aug 1;96(8):E306-E310. doi: 10.1002/ajh.26235. Epub 2021 May 25.
2021
AOU Città della Salute di Torino
AOU Novara

Ferrarini M; Foà R; Trentin L; Polliack A; Gaidano G; Cuneo A; Olivieri J; Rossi D; Di Raimondo F; Cutrona G; Jaksic O; Fronza G; Neri A; Bomben R; Biagi A; Del Giudice I; Angeletti I; Galimberti S; Rago A; D'Arrigo G; Vigna E; Tripepi G; Martino EA; Al-Janazreh H; Zucchetto A; Rossi FM; Consoli U; Scortechini I; Recchia AG; et alii...

2021
AOU Città della Salute di Torino
AOU Novara

Ferrarini M; Trentin L; Foà R; Polliack A; Di Raimondo F; Gaidano G; Cuneo A; Rossi D; Cutrona G; Olivieri J; Menichini P; Monti P; Neri A; Fronza G; Bomben R; Del Giudice I; Angeletti I; Biagi A; Galimberti S; Rago A; D Arrigo G; Martino EA; Cassin R; Vigna E; Al-Janazreh H; Rossi FM; Zucchetto A; Scortechini I; Consoli U; et alii...

Comparison of ibrutinib and idelalisib plus rituximab in real-life relapsed/resistant chronic lymphocytic leukemia cases. in European journal of haematology / Eur J Haematol. 2021 Apr;106(4):493-499. doi: 10.1111/ejh.13573. Epub 2021 Jan 28.
2021
AOU Città della Salute di Torino
AOU Novara

Ferrarini M; Foà R; Trentin L; Polliack A; Gaidano G; Cuneo A; Di Raimondo F; Rossi D; Jaksic O; Cutrona G; Menichini P; Fronza G; Monti P; Neri A; Del Giudice I; Bomben R; Biagi A; Rago A; Angeletti I; D'Arrigo G; Galimberti S; Mendicino F; Cassin R; Martino EA; Vigna E; Al-Janazreh H; Zucchetto A; Scortechini I; Rossi FM; et alii...

Stiffer Spleen Predicts Higher Bone Marrow Fibrosis and Higher JAK2 Allele Burden in Patients With Myeloproliferative Neoplasms. in Frontiers in oncology / Front Oncol. 2021 Oct 26;11:777730. doi: 10.3389/fonc.2021.777730. eCollection 2021.
2021
AOU Novara

Moia R; Cittone MG; Boggione P; Manfredi GF; Favini C; Awikeh B; Pedrinelli AR; Mahmoud AM; Nicolosi M; Bellan M; Sainaghi PP; Pirisi M; Gaidano G; Patriarca A; Rigamonti C;

Lymphocyte Doubling Time As A Key Prognostic Factor To Predict Time To First Treatment In Early-Stage Chronic Lymphocytic Leukemia. in Frontiers in oncology / Front Oncol. 2021 Aug 2;11:684621. doi: 10.3389/fonc.2021.684621. eCollection 2021.
2021
AOU Novara

Morabito F; Tripepi G; Moia R; Recchia AG; Boggione P; Mauro FR; Bossio S; D'Arrigo G; Martino EA; Vigna E; Storino F; Fronza G; Di Raimondo F; Rossi D; Condoluci A; Colombo M; Fais F; Fabris S; Foa R; Cutrona G; Gentile M; Montserrat E; Gaidano G; Ferrarini M; Neri A;

Validation of a survival-risk score (SRS) in relapsed/refractory CLL patients treated with idelalisib-rituximab. in Blood cancer journal / Blood Cancer J. 2020 Sep 16;10(9):92. doi: 10.1038/s41408-020-00358-3.
2020
AOU Città della Salute di Torino
AOU Novara

Di Raimondo F; Fronza G; Cutrona G; Neri A; Bomben R; Angeletti I; D'Arrigo G; Tripepi G; Vitale C; Al-Janazreh H; Zucchetto A; Rossi FM; Scortechini I; Consoli U; Loseto G; Pietrasanta D; Recchia AG; Moia R; Bossio S; Mendicino F; Lucia E; Vigna E; Chiarenza A; Varettoni M; Murru R; Laurenti L; Mauro FR; Sportoletti P; Reda G; et alii...

Precision Medicine Management of Chronic Lymphocytic Leukemia. in Cancers / Cancers (Basel). 2020 Mar 10;12(3):642. doi: 10.3390/cancers12030642.
2020
AOU Novara

Moia R; Patriarca A; Schipani M; Ferri V; Favini C; Sagiraju S; Al Essa W; Gaidano G;

Anti-rasburicase antibodies induce clinical refractoriness by inhibiting the enzyme catalytic activity. in Hematological oncology / Hematol Oncol. 2020 Apr;38(2):204-206. doi: 10.1002/hon.2700. Epub 2020 Jan 27.
2020
AOU Novara

Moia R; Boggio E; Gigliotti L; Crisà E; De Paoli L; Margiotta Casaluci G; Rolla R; Patriarca A; Gaidano G; Dianzani U; Bruna R;

Biological and clinical implications of BIRC3 mutations in chronic lymphocytic leukemia. in Haematologica / Haematologica. 2020 Jan 31;105(2):448-456. doi: 10.3324/haematol.2019.219550. Print 2020.
2020
AOU Città della Salute di Torino
AOU Novara

Rossi D; Gaidano G; Foà R; Deaglio S; Catherwood M; Boldorini RL; Gattei V; Cuneo A; Follenzi A; Poeta GD; Bertoni F; Lawless S; Thornton P; Mills K; Donaldson D; Weir P; Motta M; Laurenti L; Tedeschi A; Perbellini O; Coscia M; Marasca R; Rigolin GM; Chiarenza A; Visco C; Rossi FM; Bomben R; Cortelezzi A; Zaja F; et alii...

Late relapse in patients with diffuse large B-cell lymphoma: impact of rituximab on their incidence and outcome. in British journal of haematology / Br J Haematol. 2019 Nov;187(4):478-487. doi: 10.1111/bjh.16106. Epub 2019 Aug 5.
2019
AOU Novara

Vannata B; Conconi A; Winkler J; Cascione L; Margiotta Casaluci G; Nassi L; Moia R; Pirosa MC; Moccia AA; Stathis A; Rossi D; Gaidano G; Zucca E;